Drug
Mevrometostat
Mevrometostat: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mevrometostat (PF-06821497) NCT03460977 | Phase 1 | Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Latest
No recent events.
Follow Mevrometostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.